A fundamentally new drug for multiple sclerosis

26 July 2017, 21:21 | Health 
фото с NeBoley.com.ua

American scientists report the successful completion of the first phase of a drug test for the treatment of multiple sclerosis. During experiments on laboratory mouse models of this disease, scientists managed to restore the animals myelin sheaths of nerve fibers, according to the Internet edition for girls and women from 14 to 35 years old Pannochka. Net The cause of the development of multiple sclerosis is the destruction of the myelin sheath of nerve cell processes - axons. As a result, conduction of nerve impulses is broken, which leads to the development of symptoms of the disease - speech disorders and loss of coordination of movements, limb tremor, muscle spasms and paralysis.

Modern methods of treating multiple sclerosis can slow this pathological process, but do not allow the restoration of the function of damaged nerve cells. The fact is that with multiple sclerosis, the process of remyelination of nerve cells, which normally occurs in the body of a healthy person,.

A report of researchers from the American Mayo Clinic in Rochester, first used to treat monoclonal antibodies, was presented today at a conference of the American Neurological Society.

Synthesized by scientists, the antibody, can trigger the process of remyelination in the cells of the brain and spinal cord. The source of the antibody is a colony of immune cells, originating from one, genetically modified precursor cell.

According to researchers, within five weeks after the introduction of the experimental preparation, experimental animals underwent intensive recovery of myelin sheaths. The achieved effect allows us to count not only on slowing the development of the disease, but also on partial restoration of already lost functions.

The authors of the study Arthur Warrington (Arthur Warrington) and Moses Rodriguez (Moses Rodriguez) consider the achieved result very encouraging and express the hope for an early start of clinical trials of the drug. However, even with the most successful outcome, the widespread use of the drug at this stage of development will be possible only in a few years.

Medicinform. Net.

Keywords:.

По материалам: pannochka.net